Comparison of Urinary and Serum CA 19-9 as Markers of Early Stage Urothelial Carcinoma (original) (raw)

Urinary Bladder Cancer Susceptibility Markers. What Do We Know about Functional Mechanisms?

Gerald Verhaegh

International Journal of Molecular Sciences, 2013

View PDFchevron_right

CD 10 Expression Intensity in Various Grades and Stages of Urothelial Carcinoma of Urinary Bladder

Muhammad Sajjad Abbasi

Journal of the College of Physicians and Surgeons Pakistan Jcpsp, 2014

View PDFchevron_right

Immunophenotype of High-Grade Prostatic Adenocarcinoma and Urothelial Carcinoma

Brian Hutchinson

Modern Pathology, 2000

View PDFchevron_right

Significance of CA19-9 in predicting the prognosis of urothelial carcinoma: a hospital based study from Nepal

BRIJESH SATHIAN, Dipendra Kumar Jha

Asian Pacific journal of cancer prevention : APJCP, 2013

View PDFchevron_right

Urinary Tract Large Cell Neuroendocrine Carcinoma

Alessia Cimadamore

Encyclopedia of Pathology, 2020

View PDFchevron_right

Can urinary biomarkers replace cystoscopic examination in bladder cancer surveillance?

Benjamin Nisman

Expert Review of Anticancer Therapy, 2010

View PDFchevron_right

Bladder cancer

Öner M Şanlı

Nature Reviews Disease Primers, 2017

View PDFchevron_right

Urinary laminin-γ2 is a novel biomarker of non-muscle invasive urothelial carcinoma

Naohiko Koshikawa

Cancer Science, 2015

View PDFchevron_right

Proliferating cell nuclear antigen but not p53 or human papillomavirus DNA correlates with advanced clinical stage in renal cell carcinoma

Ylermi Soini

Histopathology, 1994

View PDFchevron_right

Non Urothelial Bladder Cancers: A Case Series

tarun kumar

Indian Journal of Surgical Oncology, 2012

View PDFchevron_right

Low utility of CYFRA 21-1 serum levels for diagnosis and follow-up in bladder cancer patients

Juan Antonio Benítez Galán

Journal of Clinical Laboratory Analysis, 2005

View PDFchevron_right

Total and specific fluid consumption as determinants of bladder cancer risk

Charles F Lynch

International Journal of Cancer, 2006

View PDFchevron_right

Prognostic Value of the Involvement of the Urinary Collecting System in Renal Cell Carcinoma

Roberto Mario Scarpa

European Urology, 2004

View PDFchevron_right

Diagnostic value of a combined C-reactive protein and haptoglobin tests in new cases of upper tract urothelial carcinoma

Abdolamir Allameh

Journal of Basic Research in Medical Sciences, 2016

View PDFchevron_right

Subepithelial growth patterns in urothelial carcinoma—frequency and prognostic significance

Kevin Zorn, Amos Shapiro

Urologic Oncology: Seminars and Original Investigations, 2012

View PDFchevron_right

Bladder cancer, a review of the environmental risk factors

Maria Dusinska

Environmental Health, 2012

View PDFchevron_right

Kidney Cancer, Version 3.2015

Steven Hancock

View PDFchevron_right

Evaluation of CA125 and CA19-9 during different Stages of Urothelial Carcinoma In Pre and Post-therapeutic level

IOSR JDMS

View PDFchevron_right

Considerations on implementing diagnostic markers into clinical decision making in bladder cancer

Marta Sanchez-carbayo

Urologic Oncology: Seminars and Original Investigations, 2010

View PDFchevron_right

Ureterocele urothelial carcinoma: managing a rare presentation

Juan Carlos Astigueta

ecancermedicalscience, 2016

View PDFchevron_right

Delaying Cancer Cases in Urology during COVID-19: Review of the Literature

Timothy Masterson

Journal of Urology, 2020

View PDFchevron_right

Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: systematic review and meta-analysis

Michael Koutsilieris

BMC Cancer, 2011

View PDFchevron_right

A Systematic Review of the Diagnostic and Prognostic Value of Urinary Protein Biomarkers in Urothelial Bladder Cancer

andi abeshi

Bladder Cancer, 2016

View PDFchevron_right

Bladder Cancer: A Simple Model Becomes Complex

Vincenzo Gentile

Current Genomics, 2012

View PDFchevron_right

Polyclonal antibody from 47 kDa protein of bladder cancer is sensitive and specific for detection of bladder cancer

Basuki Purnomo

Biomarkers and Genomic Medicine, 2014

View PDFchevron_right